Conditioned media from (pre)adipocytes stimulate fibrinogen and PAI-1 production by HepG2 hepatoma cells

Background: Obesity is associated with a prothrombotic state, which may contribute to the increased risk of thrombotic events. Objective: To assess the effects of (pre)adipocyte-derived adipokines on fibrinogen, plasminogen activator inhibitor-1 (PAI-1) and tissue factor (TF) production by hepatocyt...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Nutrition & diabetes Ročník 2; číslo 12; s. e52
Hlavní autoři: Faber, D R, Kalkhoven, E, Westerink, J, Bouwman, J J, Monajemi, H M, Visseren, F L J
Médium: Journal Article
Jazyk:angličtina
Vydáno: London Nature Publishing Group UK 01.12.2012
Nature Publishing Group
Témata:
631/45/127
692/698/2741/288/2032
692/699/1702/393
692/699/75/567
Clinical Nutrition
Diabetes
Epidemiology
Internal Medicine
Medicine
Medicine & Public Health
Metabolic Diseases
Original
original-article
thrombosis
abdominal obesity
liver
inflammation
adipocytes
ISSN:2044-4052, 2044-4052
On-line přístup:Získat plný text
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
Abstract Background: Obesity is associated with a prothrombotic state, which may contribute to the increased risk of thrombotic events. Objective: To assess the effects of (pre)adipocyte-derived adipokines on fibrinogen, plasminogen activator inhibitor-1 (PAI-1) and tissue factor (TF) production by hepatocytes. Methods: HepG2 hepatocytes were incubated with conditioned media (CM) derived from preadipocytes and adipocytes, which had been untreated or prestimulated with tumor necrosis factor (TNF)-α, interleukin (IL)-1β or IL-6. After 24 h, supernatants and cell lysates were harvested for measurement of fibrinogen, PAI-1 and TF. Results: (Pre)adipocyte CM significantly enhanced the production of PAI-1 by HepG2 cells 2.5- to 4.4-fold. CM from cytokine-stimulated (pre)adipocytes significantly induced fibrinogen secretion 1.5- to 4.2-fold. TF production was not affected by the CM. After specific depletion of TNF-α, IL-1β or IL-6 from the CM, IL-6 was shown to be the most prominent stimulus of fibrinogen secretion and IL-1β of PAI-1 secretion. In addition, fibrinogen, PAI-1 and tissue factor production was evaluated by direct stimulation of HepG2 cells with TNF-α, IL-1β or IL-6. IL-6 enhanced fibrinogen synthesis 4.3-fold ( P <0.01), whereas IL-1β induced PAI-1 production 5.0-fold ( P <0.01). Gene expression analyses showed that TNF-α and IL-1β stimulate the adipocyte expression of TNF-α, IL-1β and IL-6. Cytokine stimulation of adipocytes may thus have induced an inflammatory response, which may have stimulated fibrinogen and PAI-1 production by HepG2 cells more potently. Conclusions: SGBS (pre)adipocytes release cytokines that increase the production of fibrinogen and PAI-1 by HepG2 cells. IL-6 and IL-1β produced by (pre)adipocytes were the strongest inducers of fibrinogen and PAI-1 secretion, respectively.
AbstractList Obesity is associated with a prothrombotic state, which may contribute to the increased risk of thrombotic events.BACKGROUNDObesity is associated with a prothrombotic state, which may contribute to the increased risk of thrombotic events.To assess the effects of (pre)adipocyte-derived adipokines on fibrinogen, plasminogen activator inhibitor-1 (PAI-1) and tissue factor (TF) production by hepatocytes.OBJECTIVETo assess the effects of (pre)adipocyte-derived adipokines on fibrinogen, plasminogen activator inhibitor-1 (PAI-1) and tissue factor (TF) production by hepatocytes.HepG2 hepatocytes were incubated with conditioned media (CM) derived from preadipocytes and adipocytes, which had been untreated or prestimulated with tumor necrosis factor (TNF)-α, interleukin (IL)-1β or IL-6. After 24 h, supernatants and cell lysates were harvested for measurement of fibrinogen, PAI-1 and TF.METHODSHepG2 hepatocytes were incubated with conditioned media (CM) derived from preadipocytes and adipocytes, which had been untreated or prestimulated with tumor necrosis factor (TNF)-α, interleukin (IL)-1β or IL-6. After 24 h, supernatants and cell lysates were harvested for measurement of fibrinogen, PAI-1 and TF.(Pre)adipocyte CM significantly enhanced the production of PAI-1 by HepG2 cells 2.5- to 4.4-fold. CM from cytokine-stimulated (pre)adipocytes significantly induced fibrinogen secretion 1.5- to 4.2-fold. TF production was not affected by the CM. After specific depletion of TNF-α, IL-1β or IL-6 from the CM, IL-6 was shown to be the most prominent stimulus of fibrinogen secretion and IL-1β of PAI-1 secretion. In addition, fibrinogen, PAI-1 and tissue factor production was evaluated by direct stimulation of HepG2 cells with TNF-α, IL-1β or IL-6. IL-6 enhanced fibrinogen synthesis 4.3-fold (P<0.01), whereas IL-1β induced PAI-1 production 5.0-fold (P<0.01). Gene expression analyses showed that TNF-α and IL-1β stimulate the adipocyte expression of TNF-α, IL-1β and IL-6. Cytokine stimulation of adipocytes may thus have induced an inflammatory response, which may have stimulated fibrinogen and PAI-1 production by HepG2 cells more potently.RESULTS(Pre)adipocyte CM significantly enhanced the production of PAI-1 by HepG2 cells 2.5- to 4.4-fold. CM from cytokine-stimulated (pre)adipocytes significantly induced fibrinogen secretion 1.5- to 4.2-fold. TF production was not affected by the CM. After specific depletion of TNF-α, IL-1β or IL-6 from the CM, IL-6 was shown to be the most prominent stimulus of fibrinogen secretion and IL-1β of PAI-1 secretion. In addition, fibrinogen, PAI-1 and tissue factor production was evaluated by direct stimulation of HepG2 cells with TNF-α, IL-1β or IL-6. IL-6 enhanced fibrinogen synthesis 4.3-fold (P<0.01), whereas IL-1β induced PAI-1 production 5.0-fold (P<0.01). Gene expression analyses showed that TNF-α and IL-1β stimulate the adipocyte expression of TNF-α, IL-1β and IL-6. Cytokine stimulation of adipocytes may thus have induced an inflammatory response, which may have stimulated fibrinogen and PAI-1 production by HepG2 cells more potently.SGBS (pre)adipocytes release cytokines that increase the production of fibrinogen and PAI-1 by HepG2 cells. IL-6 and IL-1β produced by (pre)adipocytes were the strongest inducers of fibrinogen and PAI-1 secretion, respectively.CONCLUSIONSSGBS (pre)adipocytes release cytokines that increase the production of fibrinogen and PAI-1 by HepG2 cells. IL-6 and IL-1β produced by (pre)adipocytes were the strongest inducers of fibrinogen and PAI-1 secretion, respectively.
Obesity is associated with a prothrombotic state, which may contribute to the increased risk of thrombotic events. To assess the effects of (pre)adipocyte-derived adipokines on fibrinogen, plasminogen activator inhibitor-1 (PAI-1) and tissue factor (TF) production by hepatocytes. HepG2 hepatocytes were incubated with conditioned media (CM) derived from preadipocytes and adipocytes, which had been untreated or prestimulated with tumor necrosis factor (TNF)-α, interleukin (IL)-1β or IL-6. After 24 h, supernatants and cell lysates were harvested for measurement of fibrinogen, PAI-1 and TF. (Pre)adipocyte CM significantly enhanced the production of PAI-1 by HepG2 cells 2.5- to 4.4-fold. CM from cytokine-stimulated (pre)adipocytes significantly induced fibrinogen secretion 1.5- to 4.2-fold. TF production was not affected by the CM. After specific depletion of TNF-α, IL-1β or IL-6 from the CM, IL-6 was shown to be the most prominent stimulus of fibrinogen secretion and IL-1β of PAI-1 secretion. In addition, fibrinogen, PAI-1 and tissue factor production was evaluated by direct stimulation of HepG2 cells with TNF-α, IL-1β or IL-6. IL-6 enhanced fibrinogen synthesis 4.3-fold (P<0.01), whereas IL-1β induced PAI-1 production 5.0-fold (P<0.01). Gene expression analyses showed that TNF-α and IL-1β stimulate the adipocyte expression of TNF-α, IL-1β and IL-6. Cytokine stimulation of adipocytes may thus have induced an inflammatory response, which may have stimulated fibrinogen and PAI-1 production by HepG2 cells more potently. SGBS (pre)adipocytes release cytokines that increase the production of fibrinogen and PAI-1 by HepG2 cells. IL-6 and IL-1β produced by (pre)adipocytes were the strongest inducers of fibrinogen and PAI-1 secretion, respectively.
Background: Obesity is associated with a prothrombotic state, which may contribute to the increased risk of thrombotic events. Objective: To assess the effects of (pre)adipocyte-derived adipokines on fibrinogen, plasminogen activator inhibitor-1 (PAI-1) and tissue factor (TF) production by hepatocytes. Methods: HepG2 hepatocytes were incubated with conditioned media (CM) derived from preadipocytes and adipocytes, which had been untreated or prestimulated with tumor necrosis factor (TNF)-α, interleukin (IL)-1β or IL-6. After 24 h, supernatants and cell lysates were harvested for measurement of fibrinogen, PAI-1 and TF. Results: (Pre)adipocyte CM significantly enhanced the production of PAI-1 by HepG2 cells 2.5- to 4.4-fold. CM from cytokine-stimulated (pre)adipocytes significantly induced fibrinogen secretion 1.5- to 4.2-fold. TF production was not affected by the CM. After specific depletion of TNF-α, IL-1β or IL-6 from the CM, IL-6 was shown to be the most prominent stimulus of fibrinogen secretion and IL-1β of PAI-1 secretion. In addition, fibrinogen, PAI-1 and tissue factor production was evaluated by direct stimulation of HepG2 cells with TNF-α, IL-1β or IL-6. IL-6 enhanced fibrinogen synthesis 4.3-fold ( P <0.01), whereas IL-1β induced PAI-1 production 5.0-fold ( P <0.01). Gene expression analyses showed that TNF-α and IL-1β stimulate the adipocyte expression of TNF-α, IL-1β and IL-6. Cytokine stimulation of adipocytes may thus have induced an inflammatory response, which may have stimulated fibrinogen and PAI-1 production by HepG2 cells more potently. Conclusions: SGBS (pre)adipocytes release cytokines that increase the production of fibrinogen and PAI-1 by HepG2 cells. IL-6 and IL-1β produced by (pre)adipocytes were the strongest inducers of fibrinogen and PAI-1 secretion, respectively.
Background:Obesity is associated with a prothrombotic state, which may contribute to the increased risk of thrombotic events.Objective:To assess the effects of (pre)adipocyte-derived adipokines on fibrinogen, plasminogen activator inhibitor-1 (PAI-1) and tissue factor (TF) production by hepatocytes.Methods:HepG2 hepatocytes were incubated with conditioned media (CM) derived from preadipocytes and adipocytes, which had been untreated or prestimulated with tumor necrosis factor (TNF)-α, interleukin (IL)-1β or IL-6. After 24 h, supernatants and cell lysates were harvested for measurement of fibrinogen, PAI-1 and TF.Results:(Pre)adipocyte CM significantly enhanced the production of PAI-1 by HepG2 cells 2.5- to 4.4-fold. CM from cytokine-stimulated (pre)adipocytes significantly induced fibrinogen secretion 1.5- to 4.2-fold. TF production was not affected by the CM. After specific depletion of TNF-α, IL-1β or IL-6 from the CM, IL-6 was shown to be the most prominent stimulus of fibrinogen secretion and IL-1β of PAI-1 secretion. In addition, fibrinogen, PAI-1 and tissue factor production was evaluated by direct stimulation of HepG2 cells with TNF-α, IL-1β or IL-6. IL-6 enhanced fibrinogen synthesis 4.3-fold (P<0.01), whereas IL-1β induced PAI-1 production 5.0-fold (P<0.01). Gene expression analyses showed that TNF-α and IL-1β stimulate the adipocyte expression of TNF-α, IL-1β and IL-6. Cytokine stimulation of adipocytes may thus have induced an inflammatory response, which may have stimulated fibrinogen and PAI-1 production by HepG2 cells more potently.Conclusions:SGBS (pre)adipocytes release cytokines that increase the production of fibrinogen and PAI-1 by HepG2 cells. IL-6 and IL-1β produced by (pre)adipocytes were the strongest inducers of fibrinogen and PAI-1 secretion, respectively.
Author Faber, D R
Monajemi, H M
Visseren, F L J
Kalkhoven, E
Bouwman, J J
Westerink, J
Author_xml – sequence: 1
  givenname: D R
  surname: Faber
  fullname: Faber, D R
  organization: Department of Vascular Medicine, University Medical Center Utrecht
– sequence: 2
  givenname: E
  surname: Kalkhoven
  fullname: Kalkhoven, E
  organization: Department of Metabolic Diseases, UMC Utrecht
– sequence: 3
  givenname: J
  surname: Westerink
  fullname: Westerink, J
  organization: Department of Vascular Medicine, University Medical Center Utrecht
– sequence: 4
  givenname: J J
  surname: Bouwman
  fullname: Bouwman, J J
  organization: Department of Microbiology, Diakonessen Hospital Utrecht
– sequence: 5
  givenname: H M
  surname: Monajemi
  fullname: Monajemi, H M
  organization: Department of Vascular Medicine, University Medical Center Utrecht
– sequence: 6
  givenname: F L J
  surname: Visseren
  fullname: Visseren, F L J
  email: F.L.J.Visseren@umcutrecht.nl
  organization: Department of Vascular Medicine, University Medical Center Utrecht
BackLink https://www.ncbi.nlm.nih.gov/pubmed/23208413$$D View this record in MEDLINE/PubMed
BookMark eNp1kcFrHCEUxqWkNGmaW89F6CWFzlafzq5zCYSlTQKB5NCexVFn1zCjU3UK-9_XYZOyCem76MPf-_ie33t05IO3CH2kZEEJE9_8lM0CCIUF1G_QCRDOK05qODq4H6OzlB5IqSUBsRTv0DEwIIJTdoK26-CNy67IGjxY4xTuYhjw-RjtF2XcGPQu24RTdsPUq2xx59rofNhYj5U3-P7ypqJ4jMFMepbB7Q5f2_EK8NaOKodBYW37Pn1AbzvVJ3v2eJ6iXz--_1xfV7d3Vzfry9tK85rkClS9EqZbCc2ZaYig2jBtlqKxVAul2bLhdekIV7QFSnSjubGka1pemw54y07RxV53nNqyj7Y-R9XLMbpBxZ0MysnnL95t5Sb8kazmwKEpAuePAjH8nmzKcnBpXkF5G6YkKZRiQCkv6OcX6EOYoi_rSboSgjC-4lCoT4eO_ll5CqEAsAd0DClF20ntspo_sxh0vaREzmHLOWw5hy2hLkNfXww96f4Hr_Z4Kpjf2Hhg9TX-L1JeuuY
CitedBy_id crossref_primary_10_1088_1748_605X_ac4611
crossref_primary_10_1097_QAD_0000000000000477
crossref_primary_10_4142_jvs_2021_22_e86
crossref_primary_10_1186_s13018_024_05089_w
crossref_primary_10_1016_j_intimp_2013_04_002
crossref_primary_10_1007_s13365_017_0531_2
crossref_primary_10_1038_s41366_022_01199_9
Cites_doi 10.1111/j.1467-789X.2007.00316.x
10.1016/j.ejphar.2006.11.052
10.1016/0014-5793(89)80476-4
10.1161/CIRCULATIONAHA.107.739714
10.1126/science.1103160
10.1161/ATVBAHA.107.147538
10.1210/jc.2004-1292
10.1007/s001250050868
10.1073/pnas.83.12.4533
10.1038/oby.2003.131
10.1161/01.ATV.16.3.368
10.1038/sj.ijo.0801520
10.1016/j.bbrc.2006.04.173
10.1038/oby.2008.64
10.1016/j.atherosclerosis.2010.04.029
10.1016/j.febslet.2007.07.076
10.1055/s-2005-871741
10.1111/j.1572-0241.2007.01774.x
10.1055/s-2003-39078
10.1002/hep.22404
10.1093/oxfordjournals.aje.a008725
10.1073/pnas.95.13.7591
10.1172/JCI200319246
10.1161/ATVBAHA.111.224386
10.1016/S0140-6736(05)67663-5
10.1111/j.1467-789X.2009.00593.x
10.1161/01.ATV.17.12.3399
10.1172/JCI29069
10.1210/jcem.87.2.8214
10.1002/hep.22350
10.1161/01.ATV.20.6.1682
10.1210/jc.2007-2191
10.1161/ATVBAHA.107.159228
10.2337/db06-1656
10.1096/fj.05-5710fje
10.1093/aje/kwm191
10.1172/JCI13143
ContentType Journal Article
Copyright The Author(s) 2012
Copyright Nature Publishing Group Dec 2012
Copyright © 2012 Macmillan Publishers Limited 2012 Macmillan Publishers Limited
Copyright_xml – notice: The Author(s) 2012
– notice: Copyright Nature Publishing Group Dec 2012
– notice: Copyright © 2012 Macmillan Publishers Limited 2012 Macmillan Publishers Limited
DBID C6C
AAYXX
CITATION
NPM
3V.
7X7
7XB
88E
8FI
8FJ
8FK
ABUWG
AFKRA
AZQEC
BENPR
CCPQU
DWQXO
FYUFA
GHDGH
K9.
M0S
M1P
PHGZM
PHGZT
PIMPY
PJZUB
PKEHL
PPXIY
PQEST
PQQKQ
PQUKI
PRINS
7X8
5PM
DOI 10.1038/nutd.2012.25
DatabaseName Springer Nature OA Free Journals
CrossRef
PubMed
ProQuest Central (Corporate)
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest Central UK/Ireland
ProQuest Central Essentials - QC
ProQuest Central
ProQuest One
ProQuest Central
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Health & Medical Complete (Alumni)
ProQuest Health & Medical Collection
PML(ProQuest Medical Library)
ProQuest Central Premium
ProQuest One Academic
Publicly Available Content Database (ProQuest)
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic (retired)
ProQuest One Academic UKI Edition
ProQuest Central China
MEDLINE - Academic
PubMed Central (Full Participant titles)
DatabaseTitle CrossRef
PubMed
Publicly Available Content Database
ProQuest One Academic Middle East (New)
ProQuest Central Essentials
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest One Health & Nursing
ProQuest Central China
ProQuest Central
ProQuest Health & Medical Research Collection
Health Research Premium Collection
Health and Medicine Complete (Alumni Edition)
ProQuest Central Korea
Health & Medical Research Collection
ProQuest Central (New)
ProQuest Medical Library (Alumni)
ProQuest One Academic Eastern Edition
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
ProQuest Hospital Collection (Alumni)
ProQuest Health & Medical Complete
ProQuest Medical Library
ProQuest One Academic UKI Edition
ProQuest One Academic
ProQuest One Academic (New)
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic
PubMed

Publicly Available Content Database
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: PIMPY
  name: Publicly Available Content Database
  url: http://search.proquest.com/publiccontent
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Diet & Clinical Nutrition
DocumentTitleAlternate The adipocyte–hepatocyte axis in coagulation
EISSN 2044-4052
EndPage e52
ExternalDocumentID PMC3542429
4051792051
23208413
10_1038_nutd_2012_25
Genre Journal Article
GroupedDBID 0R~
3V.
53G
5VS
70F
7X7
88E
8FI
8FJ
AAHBH
AAJSJ
ABUWG
ACGFS
ACSMW
ADBBV
ADRAZ
AENEX
AFKRA
AJTQC
ALIPV
ALMA_UNASSIGNED_HOLDINGS
AOIJS
BAWUL
BCNDV
BENPR
BPHCQ
BVXVI
C6C
CCPQU
DIK
EBLON
EBS
EJD
EMOBN
FYUFA
GROUPED_DOAJ
GX1
HMCUK
HYE
KQ8
M1P
M48
M~E
NAO
OK1
PGMZT
PIMPY
PQQKQ
PROAC
PSQYO
RNT
RNTTT
RPM
SNYQT
UKHRP
W2D
AASML
AAYXX
AFFHD
CITATION
PHGZM
PHGZT
PJZUB
PPXIY
NPM
7XB
8FK
AZQEC
DWQXO
K9.
PKEHL
PQEST
PQUKI
PRINS
7X8
5PM
ID FETCH-LOGICAL-c450t-2a578df78c43d9081cd3cd689e1c8ac3694568904a1b210c9c4de0f9b45df24b3
IEDL.DBID PIMPY
ISICitedReferencesCount 9
ISICitedReferencesURI http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000314531400002&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
ISSN 2044-4052
IngestDate Tue Nov 04 01:50:47 EST 2025
Sun Nov 09 12:43:57 EST 2025
Tue Oct 07 06:42:38 EDT 2025
Thu Jan 02 22:14:09 EST 2025
Tue Nov 18 21:26:44 EST 2025
Sat Nov 29 03:44:05 EST 2025
Fri Feb 21 02:38:39 EST 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 12
Keywords thrombosis
abdominal obesity
liver
inflammation
adipocytes
Language English
License This work is licensed under the Creative Commons Attribution-NonCommercial-No Derivative Works 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c450t-2a578df78c43d9081cd3cd689e1c8ac3694568904a1b210c9c4de0f9b45df24b3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
OpenAccessLink https://www.proquest.com/publiccontent/docview/1788034742?pq-origsite=%requestingapplication%
PMID 23208413
PQID 1788034742
PQPubID 2041914
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_3542429
proquest_miscellaneous_1222232114
proquest_journals_1788034742
pubmed_primary_23208413
crossref_citationtrail_10_1038_nutd_2012_25
crossref_primary_10_1038_nutd_2012_25
springer_journals_10_1038_nutd_2012_25
PublicationCentury 2000
PublicationDate 2012-12-01
PublicationDateYYYYMMDD 2012-12-01
PublicationDate_xml – month: 12
  year: 2012
  text: 2012-12-01
  day: 01
PublicationDecade 2010
PublicationPlace London
PublicationPlace_xml – name: London
– name: England
PublicationTitle Nutrition & diabetes
PublicationTitleAbbrev Nutr & Diabetes
PublicationTitleAlternate Nutr Diabetes
PublicationYear 2012
Publisher Nature Publishing Group UK
Nature Publishing Group
Publisher_xml – name: Nature Publishing Group UK
– name: Nature Publishing Group
References Bevilacqua, Pober, Majeau, Fiers, Cotran, Gimbrone (CR21) 1986; 83
Clement, Juge-Aubry, Sgroi, Conzelmann, Pazienza, Pittet-Cuenod (CR24) 2008; 48
Despres, Lemieux, Bergeron, Pibarot, Mathieu, Larose (CR4) 2008; 28
Yusuf, Hawken, Ounpuu, Bautista, Franzosi, Commerford (CR1) 2005; 366
Wang, Lv, Zhang, Zhu, Zhu, Sun (CR25) 2006; 345
Ozcan, Cao, Yilmaz, Lee, Iwakoshi, Ozdelen (CR32) 2004; 306
Kaptoge, White, Thompson, Wood, Lewington, Lowe (CR26) 2007; 166
van der Poorten, Milner, Hui, Hodge, Trenell, Kench (CR31) 2008; 48
Castell, Gomez-Lechon, David, Andus, Geiger, Trullenque (CR35) 1989; 242
Hori, Nakatani, Morioka, Katsuki, Gabazza, Yano (CR16) 2005; 15
Meilahn, Cauley, Tracy, Macy, Gutai, Kuller (CR6) 1996; 143
Faber, de Groot, Visseren (CR7) 2009; 10
Eriksson, Reynisdottir, Lonnqvist, Stemme, Hamsten, Arner (CR8) 1998; 41
Newell, Su, Tornqvist, Whitehead, Prins, Hutley (CR19) 2006; 20
Belalcazar, Ballantyne, Lang, Haffner, Rushing, Schwenke (CR9) 2011; 31
Wieckowska, Papouchado, Li, Lopez, Zein, Feldstein (CR30) 2008; 103
Zhang, Rexrode, van Dam, Li, Hu (CR2) 2008; 117
Mertens, Van Gaal (CR37) 2005; 5
He, Pedersen, Bruun, Lihn, Jensen, Richelsen (CR13) 2003; 35
Hori, Gabazza, Yano, Katsuki, Suzuki, Adachi (CR15) 2002; 87
Samad, Pandey, Loskutoff (CR14) 1998; 95
Seki, Healy, Fletcher, Noguchi, Gelehrter (CR38) 1999; 277
Kopp, Kopp, Steiner, Kriwanek, Krzyzanowska, Bartok (CR27) 2003; 11
Zhou, Sell, Eckardt, Yang, Eckel (CR23) 2007; 581
Cartier, Lemieux, Almeras, Tremblay, Bergeron, Despres (CR34) 2008; 93
Wabitsch, Brenner, Melzner, Braun, Moller, Heinze (CR20) 2001; 25
Godsland, Crook, Proudler, Stevenson (CR5) 2005; 90
Cigolini, Targher, Bergamo, Tonoli, Agostino, De (CR28) 1996; 16
Kotronen, Yki-Jarvinen (CR3) 2008; 28
Zhang, Kumar, Barnett, Eggo (CR40) 2001; 86
Shoelson, Lee, Goldfine (CR10) 2006; 116
Konstantinides, Schafer, Koschnick, Loskutoff (CR18) 2001; 108
Neumann, Ott, Marx, Luther, Kenngott, Gawaz (CR22) 1997; 17
Targher, Bertolini, Rodella, Lippi, Franchini, Zoppini (CR29) 2008; 16
Fontana, Eagon, Trujillo, Scherer, Klein (CR11) 2007; 56
Trayhurn (CR12) 2007; 8
Weisberg, McCann, Desai, Rosenbaum, Leibel, Ferrante (CR33) 2003; 112
Faber, van der, Westerink, Visseren (CR36) 2010; 212
Birgel, Gottschling-Zeller, Rohrig, Hauner (CR39) 2000; 20
Elbatarny, Netherton, Ovens, Ferguson, Maurice (CR17) 2007; 558
S Kaptoge (BFnutd201225_CR26) 2007; 166
A Kotronen (BFnutd201225_CR3) 2008; 28
L Zhou (BFnutd201225_CR23) 2007; 581
CW Kopp (BFnutd201225_CR27) 2003; 11
G He (BFnutd201225_CR13) 2003; 35
IF Godsland (BFnutd201225_CR5) 2005; 90
D van der Poorten (BFnutd201225_CR31) 2008; 48
U Ozcan (BFnutd201225_CR32) 2004; 306
MP Bevilacqua (BFnutd201225_CR21) 1986; 83
C Zhang (BFnutd201225_CR2) 2008; 117
Y Hori (BFnutd201225_CR16) 2005; 15
FJ Neumann (BFnutd201225_CR22) 1997; 17
P Trayhurn (BFnutd201225_CR12) 2007; 8
P Eriksson (BFnutd201225_CR8) 1998; 41
F Samad (BFnutd201225_CR14) 1998; 95
DR Faber (BFnutd201225_CR7) 2009; 10
M Wabitsch (BFnutd201225_CR20) 2001; 25
A Wieckowska (BFnutd201225_CR30) 2008; 103
G Targher (BFnutd201225_CR29) 2008; 16
EN Meilahn (BFnutd201225_CR6) 1996; 143
L Fontana (BFnutd201225_CR11) 2007; 56
S Konstantinides (BFnutd201225_CR18) 2001; 108
JV Castell (BFnutd201225_CR35) 1989; 242
S Yusuf (BFnutd201225_CR1) 2005; 366
Y Hori (BFnutd201225_CR15) 2002; 87
SE Shoelson (BFnutd201225_CR10) 2006; 116
T Seki (BFnutd201225_CR38) 1999; 277
HS Elbatarny (BFnutd201225_CR17) 2007; 558
Z Wang (BFnutd201225_CR25) 2006; 345
HH Zhang (BFnutd201225_CR40) 2001; 86
I Mertens (BFnutd201225_CR37) 2005; 5
JP Despres (BFnutd201225_CR4) 2008; 28
A Cartier (BFnutd201225_CR34) 2008; 93
FS Newell (BFnutd201225_CR19) 2006; 20
S Clement (BFnutd201225_CR24) 2008; 48
DR Faber (BFnutd201225_CR36) 2010; 212
SP Weisberg (BFnutd201225_CR33) 2003; 112
LM Belalcazar (BFnutd201225_CR9) 2011; 31
M Cigolini (BFnutd201225_CR28) 1996; 16
M Birgel (BFnutd201225_CR39) 2000; 20
18570214 - Hepatology. 2008 Sep;48(3):799-807
16712794 - Biochem Biophys Res Commun. 2006 Jul 7;345(3):976-83
9498632 - Diabetologia. 1998 Jan;41(1):65-71
17287468 - Diabetes. 2007 Apr;56(4):1010-3
3487091 - Proc Natl Acad Sci U S A. 1986 Jun;83(12):4533-7
8630661 - Arterioscler Thromb Vasc Biol. 1996 Mar;16(3):368-74
17690317 - Arterioscler Thromb Vasc Biol. 2008 Jan;28(1):27-38
15494459 - J Clin Endocrinol Metab. 2005 Jan;90(1):190-7
12734779 - Horm Metab Res. 2003 Mar;35(3):178-82
11836301 - J Clin Endocrinol Metab. 2002 Feb;87(2):660-5
12917499 - Obes Res. 2003 Aug;11(8):950-6
20494358 - Atherosclerosis. 2010 Sep;212(1):274-80
15647842 - Int J Mol Med. 2005 Feb;15(2):265-8
11714745 - J Clin Invest. 2001 Nov;108(10):1533-40
17316300 - Obes Rev. 2007 Mar;8 Suppl 1:41-4
18319319 - J Clin Endocrinol Metab. 2008 May;93(5):1931-8
14679176 - J Clin Invest. 2003 Dec;112(12):1796-808
17068114 - FASEB J. 2006 Dec;20(14):2615-7
18356555 - Arterioscler Thromb Vasc Biol. 2008 Jun;28(6):1039-49
17785713 - Am J Epidemiol. 2007 Oct 15;166(8):867-79
8546117 - Am J Epidemiol. 1996 Jan 15;143(2):159-66
11397893 - J Clin Endocrinol Metab. 2001 Jun;86(6):2817-25
17716671 - FEBS Lett. 2007 Sep 4;581(22):4303-8
18627003 - Hepatology. 2008 Aug;48(2):449-57
2464504 - FEBS Lett. 1989 Jan 2;242(2):237-9
16823477 - J Clin Invest. 2006 Jul;116(7):1793-801
16271645 - Lancet. 2005 Nov 5;366(9497):1640-9
9437185 - Arterioscler Thromb Vasc Biol. 1997 Dec;17(12):3399-405
18510618 - Am J Gastroenterol. 2008 Jun;103(6):1372-9
15486293 - Science. 2004 Oct 15;306(5695):457-61
21512162 - Arterioscler Thromb Vasc Biol. 2011 Jul;31(7):1689-95
10516146 - Am J Physiol. 1999 Oct;277(4 Pt 1):G801-9
15968580 - Semin Vasc Med. 2005 Feb;5(1):48-55
10845889 - Arterioscler Thromb Vasc Biol. 2000 Jun;20(6):1682-7
18369343 - Obesity (Silver Spring). 2008 Jun;16(6):1394-9
18362231 - Circulation. 2008 Apr 1;117(13):1658-67
9636194 - Proc Natl Acad Sci U S A. 1998 Jun 23;95(13):7591-6
11244452 - Int J Obes Relat Metab Disord. 2001 Jan;25(1):8-15
17207790 - Eur J Pharmacol. 2007 Mar 8;558(1-3):7-13
19460118 - Obes Rev. 2009 Sep;10(5):554-63
References_xml – volume: 8
  start-page: 41
  issue: Suppl 1
  year: 2007
  end-page: 44
  ident: CR12
  article-title: Adipocyte biology
  publication-title: Obes Rev
  doi: 10.1111/j.1467-789X.2007.00316.x
– volume: 15
  start-page: 265
  year: 2005
  end-page: 268
  ident: CR16
  article-title: Insulin enhanced thrombin-activable fibrinolysis inhibitor expression through PI3 kinase/Akt pathway
  publication-title: Int J Mol Med
– volume: 558
  start-page: 7
  year: 2007
  end-page: 13
  ident: CR17
  article-title: Adiponectin, ghrelin, and leptin differentially influence human platelet and human vascular endothelial cell functions: implication in obesity-associated cardiovascular diseases
  publication-title: Eur J Pharmacol
  doi: 10.1016/j.ejphar.2006.11.052
– volume: 242
  start-page: 237
  year: 1989
  end-page: 239
  ident: CR35
  article-title: Interleukin-6 is the major regulator of acute phase protein synthesis in adult human hepatocytes
  publication-title: FEBS Lett
  doi: 10.1016/0014-5793(89)80476-4
– volume: 117
  start-page: 1658
  year: 2008
  end-page: 1667
  ident: CR2
  article-title: Abdominal obesity and the risk of all-cause, cardiovascular, and cancer mortality: sixteen years of follow-up in US women
  publication-title: Circulation
  doi: 10.1161/CIRCULATIONAHA.107.739714
– volume: 306
  start-page: 457
  year: 2004
  end-page: 461
  ident: CR32
  article-title: Endoplasmic reticulum stress links obesity, insulin action, and type 2 diabetes
  publication-title: Science
  doi: 10.1126/science.1103160
– volume: 28
  start-page: 27
  year: 2008
  end-page: 38
  ident: CR3
  article-title: Fatty liver: a novel component of the metabolic syndrome
  publication-title: Arterioscler Thromb Vasc Biol
  doi: 10.1161/ATVBAHA.107.147538
– volume: 90
  start-page: 190
  year: 2005
  end-page: 197
  ident: CR5
  article-title: Hemostatic risk factors and insulin sensitivity, regional body fat distribution, and the metabolic syndrome
  publication-title: J Clin Endocrinol Metab
  doi: 10.1210/jc.2004-1292
– volume: 41
  start-page: 65
  year: 1998
  end-page: 71
  ident: CR8
  article-title: Adipose tissue secretion of plasminogen activator inhibitor-1 in non-obese and obese individuals
  publication-title: Diabetologia
  doi: 10.1007/s001250050868
– volume: 83
  start-page: 4533
  year: 1986
  end-page: 4537
  ident: CR21
  article-title: Recombinant tumor necrosis factor induces procoagulant activity in cultured human vascular endothelium: characterization and comparison with the actions of interleukin 1
  publication-title: Proc Natl Acad Sci USA
  doi: 10.1073/pnas.83.12.4533
– volume: 11
  start-page: 950
  year: 2003
  end-page: 956
  ident: CR27
  article-title: Weight loss reduces tissue factor in morbidly obese patients
  publication-title: Obes Res
  doi: 10.1038/oby.2003.131
– volume: 16
  start-page: 368
  year: 1996
  end-page: 374
  ident: CR28
  article-title: Visceral fat accumulation and its relation to plasma hemostatic factors in healthy men
  publication-title: Arterioscler Thromb Vasc Biol
  doi: 10.1161/01.ATV.16.3.368
– volume: 25
  start-page: 8
  year: 2001
  end-page: 15
  ident: CR20
  article-title: Characterization of a human preadipocyte cell strain with high capacity for adipose differentiation
  publication-title: Int J Obes Relat Metab Disord
  doi: 10.1038/sj.ijo.0801520
– volume: 345
  start-page: 976
  year: 2006
  end-page: 983
  ident: CR25
  article-title: Co-culture with fat cells induces cellular insulin resistance in primary hepatocytes
  publication-title: Biochem Biophys Res Commun
  doi: 10.1016/j.bbrc.2006.04.173
– volume: 16
  start-page: 1394
  year: 2008
  end-page: 1399
  ident: CR29
  article-title: NASH predicts plasma inflammatory biomarkers independently of visceral fat in men
  publication-title: Obesity
  doi: 10.1038/oby.2008.64
– volume: 212
  start-page: 274
  year: 2010
  end-page: 280
  ident: CR36
  article-title: Increased visceral adipose tissue mass is associated with increased C-reactive protein in patients with manifest vascular diseases
  publication-title: Atherosclerosis
  doi: 10.1016/j.atherosclerosis.2010.04.029
– volume: 581
  start-page: 4303
  year: 2007
  end-page: 4308
  ident: CR23
  article-title: Conditioned medium obtained from differentiated adipocytes and resistin induce insulin resistance in human hepatocytes
  publication-title: FEBS Lett
  doi: 10.1016/j.febslet.2007.07.076
– volume: 5
  start-page: 48
  year: 2005
  end-page: 55
  ident: CR37
  article-title: Visceral fat as a determinant of fibrinolysis and hemostasis
  publication-title: Semin Vasc Med
  doi: 10.1055/s-2005-871741
– volume: 103
  start-page: 1372
  year: 2008
  end-page: 1379
  ident: CR30
  article-title: Increased hepatic and circulating interleukin-6 levels in human nonalcoholic steatohepatitis
  publication-title: Am J Gastroenterol
  doi: 10.1111/j.1572-0241.2007.01774.x
– volume: 35
  start-page: 178
  year: 2003
  end-page: 182
  ident: CR13
  article-title: Differences in plasminogen activator inhibitor 1 in subcutaneous versus omental adipose tissue in non-obese and obese subjects
  publication-title: Horm Metab Res
  doi: 10.1055/s-2003-39078
– volume: 48
  start-page: 799
  year: 2008
  end-page: 807
  ident: CR24
  article-title: Monocyte chemoattractant protein-1 secreted by adipose tissue induces direct lipid accumulation in hepatocytes
  publication-title: Hepatology
  doi: 10.1002/hep.22404
– volume: 143
  start-page: 159
  year: 1996
  end-page: 166
  ident: CR6
  article-title: Association of sex hormones and adiposity with plasma levels of fibrinogen and PAI-1 in postmenopausal women
  publication-title: Am J Epidemiol
  doi: 10.1093/oxfordjournals.aje.a008725
– volume: 95
  start-page: 7591
  year: 1998
  end-page: 7596
  ident: CR14
  article-title: Tissue factor gene expression in the adipose tissues of obese mice
  publication-title: Proc Natl Acad Sci USA
  doi: 10.1073/pnas.95.13.7591
– volume: 112
  start-page: 1796
  year: 2003
  end-page: 1808
  ident: CR33
  article-title: Obesity is associated with macrophage accumulation in adipose tissue
  publication-title: J Clin Invest
  doi: 10.1172/JCI200319246
– volume: 31
  start-page: 1689
  year: 2011
  end-page: 1695
  ident: CR9
  article-title: Metabolic factors, adipose tissue, and plasminogen activator inhibitor-1 levels in type 2 diabetes: findings from the look AHEAD study
  publication-title: Arterioscler Thromb Vasc Biol
  doi: 10.1161/ATVBAHA.111.224386
– volume: 366
  start-page: 1640
  year: 2005
  end-page: 1649
  ident: CR1
  article-title: Obesity and the risk of myocardial infarction in 27 000 participants from 52 countries: a case–control study
  publication-title: Lancet
  doi: 10.1016/S0140-6736(05)67663-5
– volume: 10
  start-page: 554
  year: 2009
  end-page: 563
  ident: CR7
  article-title: Role of adipose tissue in haemostasis, coagulation and fibrinolysis
  publication-title: Obes Rev
  doi: 10.1111/j.1467-789X.2009.00593.x
– volume: 17
  start-page: 3399
  year: 1997
  end-page: 3405
  ident: CR22
  article-title: Effect of human recombinant interleukin-6 and interleukin-8 on monocyte procoagulant activity
  publication-title: Arterioscler Thromb Vasc Biol
  doi: 10.1161/01.ATV.17.12.3399
– volume: 116
  start-page: 1793
  year: 2006
  end-page: 1801
  ident: CR10
  article-title: Inflammation and insulin resistance
  publication-title: J Clin Invest
  doi: 10.1172/JCI29069
– volume: 87
  start-page: 660
  year: 2002
  end-page: 665
  ident: CR15
  article-title: Insulin resistance is associated with increased circulating level of thrombin-activatable fibrinolysis inhibitor in type 2 diabetic patients
  publication-title: J Clin Endocrinol Metab
  doi: 10.1210/jcem.87.2.8214
– volume: 48
  start-page: 449
  year: 2008
  end-page: 457
  ident: CR31
  article-title: Visceral fat: a key mediator of steatohepatitis in metabolic liver disease
  publication-title: Hepatology
  doi: 10.1002/hep.22350
– volume: 20
  start-page: 1682
  year: 2000
  end-page: 1687
  ident: CR39
  article-title: Role of cytokines in the regulation of plasminogen activator inhibitor-1 expression and secretion in newly differentiated subcutaneous human adipocytes
  publication-title: Arterioscler Thromb Vasc Biol
  doi: 10.1161/01.ATV.20.6.1682
– volume: 93
  start-page: 1931
  year: 2008
  end-page: 1938
  ident: CR34
  article-title: Visceral obesity and plasma glucose-insulin homeostasis: contributions of interleukin-6 and tumor necrosis factor-alpha in men
  publication-title: J Clin Endocrinol Metab
  doi: 10.1210/jc.2007-2191
– volume: 86
  start-page: 2817
  year: 2001
  end-page: 2825
  ident: CR40
  article-title: Dexamethasone inhibits tumor necrosis factor-alpha-induced apoptosis and interleukin-1 beta release in human subcutaneous adipocytes and preadipocytes
  publication-title: J Clin Endocrinol Metab
– volume: 28
  start-page: 1039
  year: 2008
  end-page: 1049
  ident: CR4
  article-title: Abdominal obesity and the metabolic syndrome: contribution to global cardiometabolic risk
  publication-title: Arterioscler Thromb Vasc Biol
  doi: 10.1161/ATVBAHA.107.159228
– volume: 56
  start-page: 1010
  year: 2007
  end-page: 1013
  ident: CR11
  article-title: Visceral fat adipokine secretion is associated with systemic inflammation in obese humans
  publication-title: Diabetes
  doi: 10.2337/db06-1656
– volume: 277
  start-page: G801
  year: 1999
  end-page: G809
  ident: CR38
  article-title: IL-1beta mediates induction of hepatic type 1 plasminogen activator inhibitor in response to local tissue injury
  publication-title: Am J Physiol
– volume: 20
  start-page: 2615
  year: 2006
  end-page: 2617
  ident: CR19
  article-title: Characterization of the transcriptional and functional effects of fibroblast growth factor-1 on human preadipocyte differentiation
  publication-title: FASEB J
  doi: 10.1096/fj.05-5710fje
– volume: 166
  start-page: 867
  year: 2007
  end-page: 879
  ident: CR26
  article-title: Associations of plasma fibrinogen levels with established cardiovascular disease risk factors, inflammatory markers, and other characteristics: individual participant meta-analysis of 154 211 adults in 31 prospective studies: the fibrinogen studies collaboration
  publication-title: Am J Epidemiol
  doi: 10.1093/aje/kwm191
– volume: 108
  start-page: 1533
  year: 2001
  end-page: 1540
  ident: CR18
  article-title: Leptin-dependent platelet aggregation and arterial thrombosis suggests a mechanism for atherothrombotic disease in obesity
  publication-title: J Clin Invest
  doi: 10.1172/JCI13143
– volume: 20
  start-page: 2615
  year: 2006
  ident: BFnutd201225_CR19
  publication-title: FASEB J
  doi: 10.1096/fj.05-5710fje
– volume: 56
  start-page: 1010
  year: 2007
  ident: BFnutd201225_CR11
  publication-title: Diabetes
  doi: 10.2337/db06-1656
– volume: 15
  start-page: 265
  year: 2005
  ident: BFnutd201225_CR16
  publication-title: Int J Mol Med
– volume: 166
  start-page: 867
  year: 2007
  ident: BFnutd201225_CR26
  publication-title: Am J Epidemiol
  doi: 10.1093/aje/kwm191
– volume: 117
  start-page: 1658
  year: 2008
  ident: BFnutd201225_CR2
  publication-title: Circulation
  doi: 10.1161/CIRCULATIONAHA.107.739714
– volume: 28
  start-page: 27
  year: 2008
  ident: BFnutd201225_CR3
  publication-title: Arterioscler Thromb Vasc Biol
  doi: 10.1161/ATVBAHA.107.147538
– volume: 558
  start-page: 7
  year: 2007
  ident: BFnutd201225_CR17
  publication-title: Eur J Pharmacol
  doi: 10.1016/j.ejphar.2006.11.052
– volume: 48
  start-page: 449
  year: 2008
  ident: BFnutd201225_CR31
  publication-title: Hepatology
  doi: 10.1002/hep.22350
– volume: 112
  start-page: 1796
  year: 2003
  ident: BFnutd201225_CR33
  publication-title: J Clin Invest
  doi: 10.1172/JCI200319246
– volume: 90
  start-page: 190
  year: 2005
  ident: BFnutd201225_CR5
  publication-title: J Clin Endocrinol Metab
  doi: 10.1210/jc.2004-1292
– volume: 277
  start-page: G801
  year: 1999
  ident: BFnutd201225_CR38
  publication-title: Am J Physiol
– volume: 306
  start-page: 457
  year: 2004
  ident: BFnutd201225_CR32
  publication-title: Science
  doi: 10.1126/science.1103160
– volume: 11
  start-page: 950
  year: 2003
  ident: BFnutd201225_CR27
  publication-title: Obes Res
  doi: 10.1038/oby.2003.131
– volume: 41
  start-page: 65
  year: 1998
  ident: BFnutd201225_CR8
  publication-title: Diabetologia
  doi: 10.1007/s001250050868
– volume: 103
  start-page: 1372
  year: 2008
  ident: BFnutd201225_CR30
  publication-title: Am J Gastroenterol
  doi: 10.1111/j.1572-0241.2007.01774.x
– volume: 20
  start-page: 1682
  year: 2000
  ident: BFnutd201225_CR39
  publication-title: Arterioscler Thromb Vasc Biol
  doi: 10.1161/01.ATV.20.6.1682
– volume: 28
  start-page: 1039
  year: 2008
  ident: BFnutd201225_CR4
  publication-title: Arterioscler Thromb Vasc Biol
  doi: 10.1161/ATVBAHA.107.159228
– volume: 87
  start-page: 660
  year: 2002
  ident: BFnutd201225_CR15
  publication-title: J Clin Endocrinol Metab
  doi: 10.1210/jcem.87.2.8214
– volume: 116
  start-page: 1793
  year: 2006
  ident: BFnutd201225_CR10
  publication-title: J Clin Invest
  doi: 10.1172/JCI29069
– volume: 5
  start-page: 48
  year: 2005
  ident: BFnutd201225_CR37
  publication-title: Semin Vasc Med
  doi: 10.1055/s-2005-871741
– volume: 31
  start-page: 1689
  year: 2011
  ident: BFnutd201225_CR9
  publication-title: Arterioscler Thromb Vasc Biol
  doi: 10.1161/ATVBAHA.111.224386
– volume: 10
  start-page: 554
  year: 2009
  ident: BFnutd201225_CR7
  publication-title: Obes Rev
  doi: 10.1111/j.1467-789X.2009.00593.x
– volume: 86
  start-page: 2817
  year: 2001
  ident: BFnutd201225_CR40
  publication-title: J Clin Endocrinol Metab
– volume: 16
  start-page: 1394
  year: 2008
  ident: BFnutd201225_CR29
  publication-title: Obesity
  doi: 10.1038/oby.2008.64
– volume: 25
  start-page: 8
  year: 2001
  ident: BFnutd201225_CR20
  publication-title: Int J Obes Relat Metab Disord
  doi: 10.1038/sj.ijo.0801520
– volume: 48
  start-page: 799
  year: 2008
  ident: BFnutd201225_CR24
  publication-title: Hepatology
  doi: 10.1002/hep.22404
– volume: 16
  start-page: 368
  year: 1996
  ident: BFnutd201225_CR28
  publication-title: Arterioscler Thromb Vasc Biol
  doi: 10.1161/01.ATV.16.3.368
– volume: 17
  start-page: 3399
  year: 1997
  ident: BFnutd201225_CR22
  publication-title: Arterioscler Thromb Vasc Biol
  doi: 10.1161/01.ATV.17.12.3399
– volume: 8
  start-page: 41
  issue: Suppl 1
  year: 2007
  ident: BFnutd201225_CR12
  publication-title: Obes Rev
  doi: 10.1111/j.1467-789X.2007.00316.x
– volume: 242
  start-page: 237
  year: 1989
  ident: BFnutd201225_CR35
  publication-title: FEBS Lett
  doi: 10.1016/0014-5793(89)80476-4
– volume: 212
  start-page: 274
  year: 2010
  ident: BFnutd201225_CR36
  publication-title: Atherosclerosis
  doi: 10.1016/j.atherosclerosis.2010.04.029
– volume: 83
  start-page: 4533
  year: 1986
  ident: BFnutd201225_CR21
  publication-title: Proc Natl Acad Sci USA
  doi: 10.1073/pnas.83.12.4533
– volume: 143
  start-page: 159
  year: 1996
  ident: BFnutd201225_CR6
  publication-title: Am J Epidemiol
  doi: 10.1093/oxfordjournals.aje.a008725
– volume: 108
  start-page: 1533
  year: 2001
  ident: BFnutd201225_CR18
  publication-title: J Clin Invest
  doi: 10.1172/JCI13143
– volume: 581
  start-page: 4303
  year: 2007
  ident: BFnutd201225_CR23
  publication-title: FEBS Lett
  doi: 10.1016/j.febslet.2007.07.076
– volume: 366
  start-page: 1640
  year: 2005
  ident: BFnutd201225_CR1
  publication-title: Lancet
  doi: 10.1016/S0140-6736(05)67663-5
– volume: 95
  start-page: 7591
  year: 1998
  ident: BFnutd201225_CR14
  publication-title: Proc Natl Acad Sci USA
  doi: 10.1073/pnas.95.13.7591
– volume: 35
  start-page: 178
  year: 2003
  ident: BFnutd201225_CR13
  publication-title: Horm Metab Res
  doi: 10.1055/s-2003-39078
– volume: 345
  start-page: 976
  year: 2006
  ident: BFnutd201225_CR25
  publication-title: Biochem Biophys Res Commun
  doi: 10.1016/j.bbrc.2006.04.173
– volume: 93
  start-page: 1931
  year: 2008
  ident: BFnutd201225_CR34
  publication-title: J Clin Endocrinol Metab
  doi: 10.1210/jc.2007-2191
– reference: 8630661 - Arterioscler Thromb Vasc Biol. 1996 Mar;16(3):368-74
– reference: 10516146 - Am J Physiol. 1999 Oct;277(4 Pt 1):G801-9
– reference: 3487091 - Proc Natl Acad Sci U S A. 1986 Jun;83(12):4533-7
– reference: 9636194 - Proc Natl Acad Sci U S A. 1998 Jun 23;95(13):7591-6
– reference: 17068114 - FASEB J. 2006 Dec;20(14):2615-7
– reference: 15647842 - Int J Mol Med. 2005 Feb;15(2):265-8
– reference: 2464504 - FEBS Lett. 1989 Jan 2;242(2):237-9
– reference: 16823477 - J Clin Invest. 2006 Jul;116(7):1793-801
– reference: 18369343 - Obesity (Silver Spring). 2008 Jun;16(6):1394-9
– reference: 18510618 - Am J Gastroenterol. 2008 Jun;103(6):1372-9
– reference: 9437185 - Arterioscler Thromb Vasc Biol. 1997 Dec;17(12):3399-405
– reference: 18356555 - Arterioscler Thromb Vasc Biol. 2008 Jun;28(6):1039-49
– reference: 21512162 - Arterioscler Thromb Vasc Biol. 2011 Jul;31(7):1689-95
– reference: 15494459 - J Clin Endocrinol Metab. 2005 Jan;90(1):190-7
– reference: 12734779 - Horm Metab Res. 2003 Mar;35(3):178-82
– reference: 14679176 - J Clin Invest. 2003 Dec;112(12):1796-808
– reference: 17716671 - FEBS Lett. 2007 Sep 4;581(22):4303-8
– reference: 12917499 - Obes Res. 2003 Aug;11(8):950-6
– reference: 11836301 - J Clin Endocrinol Metab. 2002 Feb;87(2):660-5
– reference: 15486293 - Science. 2004 Oct 15;306(5695):457-61
– reference: 16271645 - Lancet. 2005 Nov 5;366(9497):1640-9
– reference: 17316300 - Obes Rev. 2007 Mar;8 Suppl 1:41-4
– reference: 15968580 - Semin Vasc Med. 2005 Feb;5(1):48-55
– reference: 18627003 - Hepatology. 2008 Aug;48(2):449-57
– reference: 16712794 - Biochem Biophys Res Commun. 2006 Jul 7;345(3):976-83
– reference: 18319319 - J Clin Endocrinol Metab. 2008 May;93(5):1931-8
– reference: 11397893 - J Clin Endocrinol Metab. 2001 Jun;86(6):2817-25
– reference: 18570214 - Hepatology. 2008 Sep;48(3):799-807
– reference: 8546117 - Am J Epidemiol. 1996 Jan 15;143(2):159-66
– reference: 18362231 - Circulation. 2008 Apr 1;117(13):1658-67
– reference: 17690317 - Arterioscler Thromb Vasc Biol. 2008 Jan;28(1):27-38
– reference: 19460118 - Obes Rev. 2009 Sep;10(5):554-63
– reference: 10845889 - Arterioscler Thromb Vasc Biol. 2000 Jun;20(6):1682-7
– reference: 20494358 - Atherosclerosis. 2010 Sep;212(1):274-80
– reference: 9498632 - Diabetologia. 1998 Jan;41(1):65-71
– reference: 17785713 - Am J Epidemiol. 2007 Oct 15;166(8):867-79
– reference: 17207790 - Eur J Pharmacol. 2007 Mar 8;558(1-3):7-13
– reference: 17287468 - Diabetes. 2007 Apr;56(4):1010-3
– reference: 11244452 - Int J Obes Relat Metab Disord. 2001 Jan;25(1):8-15
– reference: 11714745 - J Clin Invest. 2001 Nov;108(10):1533-40
SSID ssj0000602868
Score 1.9307523
Snippet Background: Obesity is associated with a prothrombotic state, which may contribute to the increased risk of thrombotic events. Objective: To assess the effects...
Obesity is associated with a prothrombotic state, which may contribute to the increased risk of thrombotic events. To assess the effects of...
Background:Obesity is associated with a prothrombotic state, which may contribute to the increased risk of thrombotic events.Objective:To assess the effects of...
Obesity is associated with a prothrombotic state, which may contribute to the increased risk of thrombotic events.BACKGROUNDObesity is associated with a...
SourceID pubmedcentral
proquest
pubmed
crossref
springer
SourceType Open Access Repository
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage e52
SubjectTerms 631/45/127
692/698/2741/288/2032
692/699/1702/393
692/699/75/567
Clinical Nutrition
Diabetes
Epidemiology
Internal Medicine
Medicine
Medicine & Public Health
Metabolic Diseases
Original
original-article
Title Conditioned media from (pre)adipocytes stimulate fibrinogen and PAI-1 production by HepG2 hepatoma cells
URI https://link.springer.com/article/10.1038/nutd.2012.25
https://www.ncbi.nlm.nih.gov/pubmed/23208413
https://www.proquest.com/docview/1788034742
https://www.proquest.com/docview/1222232114
https://pubmed.ncbi.nlm.nih.gov/PMC3542429
Volume 2
WOSCitedRecordID wos000314531400002&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
journalDatabaseRights – providerCode: PRVAON
  databaseName: DOAJ Directory of Open Access Journals
  customDbUrl:
  eissn: 2044-4052
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0000602868
  issn: 2044-4052
  databaseCode: DOA
  dateStart: 20110101
  isFulltext: true
  titleUrlDefault: https://www.doaj.org/
  providerName: Directory of Open Access Journals
– providerCode: PRVHPJ
  databaseName: ROAD: Directory of Open Access Scholarly Resources
  customDbUrl:
  eissn: 2044-4052
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0000602868
  issn: 2044-4052
  databaseCode: M~E
  dateStart: 20100101
  isFulltext: true
  titleUrlDefault: https://road.issn.org
  providerName: ISSN International Centre
– providerCode: PRVPQU
  databaseName: Health Medical collection
  customDbUrl:
  eissn: 2044-4052
  dateEnd: 20171231
  omitProxy: false
  ssIdentifier: ssj0000602868
  issn: 2044-4052
  databaseCode: 7X7
  dateStart: 20110101
  isFulltext: true
  titleUrlDefault: https://search.proquest.com/healthcomplete
  providerName: ProQuest
– providerCode: PRVPQU
  databaseName: ProQuest Central
  customDbUrl:
  eissn: 2044-4052
  dateEnd: 20171231
  omitProxy: false
  ssIdentifier: ssj0000602868
  issn: 2044-4052
  databaseCode: BENPR
  dateStart: 20110101
  isFulltext: true
  titleUrlDefault: https://www.proquest.com/central
  providerName: ProQuest
– providerCode: PRVPQU
  databaseName: Publicly Available Content Database
  customDbUrl:
  eissn: 2044-4052
  dateEnd: 20171231
  omitProxy: false
  ssIdentifier: ssj0000602868
  issn: 2044-4052
  databaseCode: PIMPY
  dateStart: 20110101
  isFulltext: true
  titleUrlDefault: http://search.proquest.com/publiccontent
  providerName: ProQuest
link http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3fb9MwED6xlgdeGL_JGJWRYAKhqE7iJPYTGqNje1gVIZDKU5TYjlppS0KbIu2Fv51z4oSNAU-85CE5NU7vfP7Od_4O4KUoqK9VrNxIhNRlUgYuqjl3sygTKjZxs1Zts4l4PueLhUjs8eiNLavsfWLrqDu2Z1O3jU54qippdsynHkZuNGAY172rv7mmh5TJtdqGGjswNsRbfATj5PQs-TrsudAIV9OI2_p3GvBpuW0MXajnt72yr65MN-DmzarJ31Kn7Yp0vPt_v-Ue3LXIlBx2pnQfbunyATgfVrohB8TSh56Tec_e_xCWR5XJdxuqI0XaEyjEHFYhr-u1fpOpVV3JSwSyBJ3IhWkSpklhzheUFdosyUpFksNT1yN1xzmLP0PyS3Ki648-WeIi2VQXGTF5hc0j-HI8-3x04trGDa5kIW1cP0M_oIqYSxYogaBDqkCqiAvtSZ7JIBII27igLPNyDDmlkExpWoicharwWR48hlGJg38KxCukjBB05EprhtEcAkYdROjCeeELToUDb3ulpdKympvmGudpm10PeGpUnBoVp37owKtBuu7YPP4it98rLrVzepP-0pMDL4bHOBvNX5GVutqijG_wFgbVzIEnnbkML8L7lCNmcCC-ZkiDgGH6vv6kXC1bxu8gZAil8GMPepO7Mqw_jH_v3-N_BneMYFeVsw-jZr3Vz-G2_N6sNusJ7MSLuL3yCYzfz-bJp0m7VYHXsx-ziZ1VPwFmUzCu
linkProvider ProQuest
linkToHtml http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1Lb9QwEB6VggQX3o9AASPRCoSiOrY3sQ8IVS1lVy2rHoq0tzSxHe1KbRJ2s6D9U_xGxnnRUuDWA9fYSfz4PPONPZ4BeK0yyqyJjB-qAfWF1tzHaU79JEyUiZzdbE2dbCIaj-Vkoo7W4Ed3F8a5VXYysRbUptBuj3w7QFuNcoGW3Ifyq--yRrnT1S6FRgOLA7v6jibb4v1oD-d3k7H9j8e7Q7_NKuBrMaCVzxIEqckiqQU3CjWiNlybUCobaJloHirkFFJRkQQp2kNaaWEszVQqBiZjIuX43WtwHeV45FzIoknU7-nQELV1KFv_esrldr6sXDjSgNW5uM9rvkt09rJX5m9Hs7XG27_zv43VXbjdcmuy0yyGe7Bm8_vg7c1sRbZIGwD1lIy7_AMPYLpbuBN7F6zJkPoODXHXbcibcm7fJmZWFnqFVJygGDxzac4sydwNibzAVUeS3JCjnZEfkLKJmoufIemKDG35iZEpqvmqOEuIOxlZPIQvV9LxR7CeY-OfAAkyrUOkTamxVqA9ipTX8hCVkMyYklR58K6DRazbuOwuPchpXPsHcBk7EMUORDEbeLDZ1y6beCR_qbfRQSNupdIi_oULD171xShP3FAkuS2WWIc5xsjQTPbgcQPI_kf4nEpkPR5EF6DaV3Cxyi-W5LNpHbOcDwSSQezsVgfqc836Q_uf_rv9L-Hm8PjzYXw4Gh88g1vupcbHaAPWq_nSPocb-ls1W8xf1CuUwMlVw_wnl_J62Q
linkToPdf http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1Nb9QwEB2VghAXvqGBAkaiFQhFm9hOYh8QqrosXRWt9gDS3kJiO9qV2iTdzYL2r_HrGOeLlgK3HrgmTuIkzzNv7PE8gFcy86jRkXZDGXguV4q5-JtTNwkTqSMbNxtdi01Ek4mYzeR0C350e2FsWmVnE2tDrQtl58gHPsZqHuMYyQ2yNi1iOhy9L89cqyBlV1o7OY0GIsdm8x3Dt9W78RD_9R6low-fD4_cVmHAVTzwKpcmCFidRUJxpiV6R6WZ0qGQxlciUSyUyC-E9HjipxgbKam4Nl4mUx7ojPKU4X2vwfWIscjKRkSzqJ_f8UL03KFoc-09Jgb5urKlSX1a63Kf94KXqO3lDM3flmlr7ze68z9_t7twu-Xc5KAZJPdgy-T3wRkuTEX2SVsY9YRMOl2CBzA_LOxKvi3ipEm9t4bYbTjkdbk0bxK9KAu1QYpO0DyeWvkzQzK7cyIvcDSSJNdkejB2fVI21XTxNiTdkCNTfqRkju6_Kk4TYldMVg_hy5W8-CPYzrHzO0D8TKkQ6VSqjeEYpyIVNixE5yQyKoUnHXjbQSRWbb12KxtyEtd5A0zEFlCxBVRMAwf2-tZlU6fkL-12O5jErbVaxb8w4sDL_jTaGfspktwUa2xDLZOkGD478LgBZ_8gPO4JZEMORBdg2zewNcwvnskX87qWOQs4kkR82f0O4Oe69Yf-P_l3_1_ATUR3_Gk8OX4Kt-w1TerRLmxXy7V5BjfUt2qxWj6vByuBr1eN8p9OaYON
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Conditioned+media+from+%28pre%29adipocytes+stimulate+fibrinogen+and+PAI-1+production+by+HepG2+hepatoma+cells&rft.jtitle=Nutrition+%26+diabetes&rft.au=Faber%2C+D+R&rft.au=Kalkhoven%2C+E&rft.au=Westerink%2C+J&rft.au=Bouwman%2C+J+J&rft.date=2012-12-01&rft.issn=2044-4052&rft.eissn=2044-4052&rft.volume=2&rft.issue=12&rft.spage=e52&rft.epage=e52&rft_id=info:doi/10.1038%2Fnutd.2012.25&rft.externalDBID=n%2Fa&rft.externalDocID=10_1038_nutd_2012_25
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2044-4052&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2044-4052&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2044-4052&client=summon